CLClaudia Francesca Lucchinetti

Claudia Francesca Lucchinetti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Claudia Francesca Lucchinetti has a total of 262 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Immunity Gone Viral

    by Sonali Ajwani, Brian G. Weinshenker, Caterina Giannini, Thomas M. Habermann, Yucai Wang, Pamela Skrabek, Abedallah Balusha, Michel Toledano, Susan E. Horsman, Claudia Francesca Lucchinetti, et al.

    Subacute cognitive decline and imbalance in aquaporin-4-antibody-seropositive neuromyelitis optica spectrum disorder (AQP4+NMOSD) treated with mycophenolate has a broad differential diagnosis, including cerebral involvement of AQP4+NMOSD, infections, or other complications of immunosuppression. In this article, we highlight the diagnostic and treatment approach in a patient with AQP4+NMOSD who developed multifocal brain lesions.

  • Open Access

    Fourier transform infrared spectroscopy detects distinct TAR DNA-binding protein 43 signatures in frontotemporal lobar degeneration

    by Rodolfo G. Gatto, Oleksandr Gakh, Jordan M. Wilkins, Arenn F. Carlos, Hossam Youssef, Yong Guo, Jennifer L. Whitwell, Keith A. Josephs, Claudia F. Lucchinetti

    Background: Frontotemporal lobar degeneration (FTLD) is a leading cause of cognitive impairment in young adults. A major pathological subtype of FTLD is characterized by positive expression of TAR DNA Binding Protein 43 (TDP-43), referred to as FTLD[TDP]. However, techniques that can be utilized to interrogate and distinguish between various subtypes of FTLD are limited. Herein, we evaluated the potential of Fourier transform infrared (FTIR) spectroscopy to inform on the biomolecular changes in FTLD and to discriminate this disease from other non-FTLD cases. Methods: Histopathologically confirmed cases from FTLD[TDP] and Alzheimer’s disease (AD) autopsy cases were evaluated using FTIR spectroscopy. Formalin-fixed paraffin-embedded (FFPE) brain tissue sections from the superior and medial temporal lobes were obtained from a single control case, an AD case, an FTLD[TDP] case, and a comorbid FTLD[TDP] case that presented with AD pathology (tau and β-amyloid; FTLD[TDP] + AD). All samples were immunostained for pathological forms of tau, β-amyloid, and TDP-43. Myelin was assessed by proteolipid protein staining. Consecutive tissue sections were scanned by FTIR spectroscopy. Spectral maps were manually segmented, matching ten grey matter (GM) and ten white matter (WM) subregions per case for analysis. Peak-area ratios from lipid and amide functional groups as detected by FTIR spectroscopy were quantified and compared. Results: Relative to the control tissue, both FTLD cases and AD showed increased ratios of amide I/II, α-helix/unordered proteins, α-helix/phosphorylated proteins, and olefinic/lipid content in GM and WM. The α-helix/unordered ratio was significantly different between FTLD cases and AD, while α-helix/unordered and α-helix/phosphorylated ratios differed significantly between FTLD[TDP] and FTLD[TDP] + AD. Across all cases and brain subregions, FTIR spectroscopy-derived amide I/II, olefinic/lipid, and carboxyl/lipid ratios significantly correlated positively with TDP-43 and tau immunoreactivity ( p -value < 0.05). Conclusion: Fourier transform infrared spectroscopy of FFPE brain tissue sections from FTLD[TDP] and AD captures disease-specific changes in the composition of proteins, lipids, and secondary structures. These findings suggest that FTIR spectroscopy can serve as a rapid and cost-effective tool for mapping and quantitating biomolecular alterations in FTLD.


  • Open Access

    Assessment of concurrent neoplasms and a paraneoplastic association in MOGAD

    by Young Nam Kwon, Nanthaya Tisavipat, Yong Guo, Stephanie B. Syc‐Mazurek, Ji Yeon Han, Jun‐Soon Kim, Kyomin Choi, Seong‐Il Oh, Seok‐Jin Choi, Eunhee Sohn, et al.

    Cases of myelin oligodendrocyte glycoprotein (MOG) antibody‐associated disease (MOGAD) co‐occurring with neoplasms have been reported. In this international, retrospective cohort study in South Korea and the USA, 16 of 445 (3.6%) patients with MOGAD had concurrent neoplasm within 2 years of MOGAD onset, resulting in a standardized incidence ratio for neoplasm of 3.10 (95% confidence interval [CI], 1.77–4.81; P < 0.001) when compared to the age‐ and country‐adjusted incidence of neoplasm in the general population. However, none of the nine tumor tissues obtained demonstrated MOG immunostaining. The slightly increased frequency without immunohistopathological evidence suggest with true paraneoplastic MOGAD is extremely rare.


  • MOG antibody-associated disease epidemiology in Olmsted County, USA, and Martinique

    by Laura Cacciaguerra, Elia Sechi, Isabelle Komla-Soukha, John J. Chen, Carin Y. Smith, Sarah M. Jenkins, Kai Guo, Vyanka Redenbaugh, James P. Fryer, Jan-Mendelt Tillema, et al.

    Objectives To report myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) epidemiology in two American regions using 2023 diagnostic criteria. Patients and methods We compared age- and sex-adjusted incidence and prevalence of MOGAD per 2023 diagnostic criteria in Olmsted County (Minnesota [USA]) and Martinique (Caribbean [FR]) (01/01/2003–12/31/2018, prevalence day) using Poisson regression. Archived sera in 68–85% were available for MOG-IgG testing by live cell-based assay at Mayo Clinic. Results Of 21 patients with MOG-IgG positivity identified, 16 fulfilled MOGAD criteria (38% female; median age of 27 years, interquartile-range [IQR 23–42]) and five with low-positive MOG-IgG did not (optic neuritis lacking supportive criteria, 2; alternative diagnosis of multiple sclerosis, 3). MOGAD prevalence was similar in Olmsted County (3.70/100,000, 95% confidence interval [CI] 0.74–6.66]) and Martinique (2.61/100,000; 95% CI 0.85–4.37, P = 0.46). MOGAD incidence was 3.00/million-person-years (95% CI 0.78–5.22) in Olmsted County and 1.18/million-person-years (95% CI 0.30–2.07) in Martinique (P = 0.08). Children represented 29% of MOGAD in Olmsted County and 11% in Martinique. During their disease course the attacks included: optic neuritis (13/16 [81%]); myelitis (6/16 [38%]); and acute disseminated encephalomyelitis (2/16 [13%]). The proportion of MOGAD among incident CNS demyelinating diseases was greater in children (13–14%) than adults (2–4%; P = 0.005). At last follow-up (median, 5 years, IQR 2–9), the median EDSS was 1.0 (IQR 0.5–2.75) with 1/16 (6%) blind in one eye and 9/16 (56%) had relapsing MOGAD. Conclusions This study provides estimates of incidence and prevalence of MOGAD in the USA and Martinique and shows that, although children are predisposed, the disease is spread broadly across the age spectrum and population-based outcomes are favorable.


  • Open Access

    Infrared spectral profiling of demyelinating activity in multiple sclerosis brain tissue

    by Oleksandr Gakh, Jordan M. Wilkins, Yong Guo, Bogdan F. Popescu, Stephen D. Weigand, Alicja Kalinowska-Lyszczarz, Claudia F. Lucchinetti

    Multiple sclerosis (MS) is a leading cause of non-traumatic disability in young adults. The highly dynamic nature of MS lesions has made them difficult to study using traditional histopathology due to the specificity of current stains. This requires numerous stains to track and study demyelinating activity in MS. Thus, we utilized Fourier transform infrared (FTIR) spectroscopy to generate holistic biomolecular profiles of demyelinating activities in MS brain tissue. Multivariate analysis can differentiate MS tissue from controls. Analysis of the absorbance spectra shows profound reductions of lipids, proteins, and phosphate in white matter lesions. Changes in unsaturated lipids and lipid chain length indicate oxidative damage in MS brain tissue. Altered lipid and protein structures suggest changes in MS membrane structure and organization. Unique carbohydrate signatures are seen in MS tissue compared to controls, indicating altered metabolic activities. Cortical lesions had increased olefinic lipid content and abnormal membrane structure in normal appearing MS cortex compared to controls. Our results suggest that FTIR spectroscopy can further our understanding of lesion evolution and disease mechanisms in MS paving the way towards improved diagnosis, prognosis, and development of novel therapeutics.


  • Open Access

    Proteomics analysis of periplaque and chronic inactive multiple sclerosis lesions

    by Jordan M. Wilkins, Kiran K. Mangalaparthi, Brian C. Netzel, William A. Sherman, Yong Guo, Alicja Kalinowska-Lyszczarz, Akhilesh Pandey, Claudia F. Lucchinetti

    Background: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system characterized by increased inflammation and immune responses, oxidative injury, mitochondrial dysfunction, and iron dyshomeostasis leading to demyelination and axonal damage. In MS, incomplete remyelination results in chronically demyelinated axons and degeneration coinciding with disability. This suggests a failure in the ability to remyelinate in MS, however, the precise underlying mechanisms remain unclear. We aimed to identify proteins whose expression was altered in chronic inactive white matter lesions and periplaque white matter in MS tissue to reveal potential pathophysiological mechanisms.Methods: Laser capture microdissection coupled to proteomics was used to interrogate spatially altered changes in formalin-fixed paraffin-embedded brain tissue from three chronic MS individuals and three controls with no apparent neurological complications. Histopathological maps guided the capture of inactive lesions, periplaque white matter, and cortex from chronic MS individuals along with corresponding white matter and cortex from control tissue. Label free quantitation by liquid chromatography tandem mass spectrometry was used to discover differentially expressed proteins between the various brain regions.Results: In addition to confirming loss of several myelin-associated proteins known to be affected in MS, proteomics analysis of chronic inactive MS lesions revealed alterations in myelin assembly, metabolism, and cytoskeletal organization. The top altered proteins in MS inactive lesions compared to control white matter consisted of PPP1R14A, ERMN, SIRT2, CARNS1, and MBLAC2.Conclusion: Our findings highlight proteome changes in chronic inactive MS white matter lesions and periplaque white matter, which may be crucial for proper myelinogenesis, bioenergetics, focal adhesions, and cellular function. This study highlights the importance and feasibility of spatial approaches such as laser capture microdissection-based proteomics analysis of pathologically distinct regions of MS brain tissue. Identification of spatially resolved changes in the proteome of MS brain tissue should aid in the understanding of pathophysiological mechanisms and the development of novel therapies.


  • Top Cited Papers
    Open Access

    New insights into neuropathology and pathogenesis of autoimmune glial fibrillary acidic protein meningoencephalomyelitis

    by Yong Guo, Verena Endmayr, Anastasia Zekeridou, Andrew McKeon, Frank Leypoldt, Katharina Hess, Alicja Kalinowska-Lyszczarz, Andrea Klang, Akos Pakozdy, Elisabeth Höftberger, et al.

    Anti-glial fibrillary acidic protein (GFAP) meningoencephalomyelitis (autoimmune GFAP astrocytopathy) is a new autoimmune central nervous system (CNS) disease diagnosable by the presence of anti-GFAP autoantibodies in the cerebrospinal fluid and presents as meningoencephalomyelitis in the majority of patients. Only few neuropathological reports are available and little is known about the pathogenic mechanisms. We performed a histopathological study of two autopsies and nine CNS biopsies of patients with anti-GFAP autoantibodies and found predominantly a lymphocytic and in one autopsy case a granulomatous inflammatory phenotype. Inflammatory infiltrates were composed of B and T cells, including tissue-resident memory T cells. Although obvious astrocytic damage was absent in the GFAP-staining, we found cytotoxic T cell-mediated reactions reflected by the presence of CD8+/perforin+/granzyme A/B+ cells, polarized towards astrocytes. MHC-class-I was upregulated in reactive astrocytes of all biopsies and two autopsies but not in healthy controls. Importantly, we observed a prominent immunoreactivity of astrocytes with the complement factor C4d. Finally, we provided insight into an early phase of GFAP autoimmunity in an autopsy of a pug dog encephalitis that was characterized by marked meningoencephalitis with selective astrocytic damage with loss of GFAP and AQP4 in the lesions.Our histopathological findings indicate that a cytotoxic T cell-mediated immune reaction is present in GFAP autoimmunity. Complement C4d deposition on astrocytes could either represent the cause or consequence of astrocytic reactivity. Selective astrocytic damage is prominent in the early phase of GFAP autoimmunity in a canine autopsy case, but mild or absent in subacute and chronic stages in human disease, probably due to the high regeneration potential of astrocytes. The lymphocytic and granulomatous phenotypes might reflect different stages of lesion development or patient-specific modifications of the immune response. Future studies will be necessary to investigate possible implications of pathological subtypes for clinical disease course and therapeutic strategies.


  • Open Access

    Peripheral nervous system manifestations of MOG antibody associated disease

    by Pranjal Gupta, Pritikanta Paul, Vyanka Redenbaugh, Yong Guo, Claudia Lucchinetti, Yahya Abdulrahman, Abhigyan Datta, Shailee Shah, Christopher J. Klein, Sean J. Pittock, et al.

    Recent studies have reported the involvement of peripheral nervous system (PNS) in association with MOG‐IgG, including isolated neuropathies. In this retrospective study we characterized the PNS involvement in MOG antibody associated disease (MOGAD). Six out of 215 MOGAD patients had PNS involvement (all polyradiculopathy) that occurred concurrently with a CNS demyelinating episode. We also demonstrated MOG expression in healthy human controls' proximal nerve root. Nine patients with true‐positive MOG‐IgG1 had PNS involvement temporally unrelated to a CNS demyelinating event. All these patients had an alternate etiology of PNS involvement. Isolated peripheral neuropathy is not a feature of MOGAD, but inflammatory nerve root involvement can occur concurrently with CNS demyelinating events.


  • Open Access

    Biomolecular alterations detected in multiple sclerosis skin fibroblasts using Fourier transform infrared spectroscopy

    by Jordan M. Wilkins, Oleksandr Gakh, Yong Guo, Bogdan Popescu, Nathan P. Staff, Claudia F. Lucchinetti

    Multiple sclerosis (MS) is the leading cause of non-traumatic disability in young adults. New avenues are needed to help predict individuals at risk for developing MS and aid in diagnosis, prognosis, and outcome of therapeutic treatments. Previously, we showed that skin fibroblasts derived from patients with MS have altered signatures of cell stress and bioenergetics, which likely reflects changes in their protein, lipid, and biochemical profiles. Here, we used Fourier transform infrared (FTIR) spectroscopy to determine if the biochemical landscape of MS skin fibroblasts were altered when compared to age- and sex-matched controls (CTRL). More so, we sought to determine if FTIR spectroscopic signatures detected in MS skin fibroblasts are disease specific by comparing them to amyotrophic lateral sclerosis (ALS) skin fibroblasts. Spectral profiling of skin fibroblasts from MS individuals suggests significant alterations in lipid and protein organization and homeostasis, which may be affecting metabolic processes, cellular organization, and oxidation status. Sparse partial least squares-discriminant analysis of spectral profiles show that CTRL skin fibroblasts segregate well from diseased cells and that changes in MS and ALS may be unique. Differential changes in the spectral profile of CTRL, MS, and ALS cells support the development of FTIR spectroscopy to detect biomolecular modifications in patient-derived skin fibroblasts, which may eventually help establish novel peripheral biomarkers.


  • Tenascin‐R Autoimmunity: Isolated Tremor Reversed with Immunotherapy

    by Binxia Yang, Andrew Brown, Andrew McKeon, J. Eric Ahlskog, Philip Tipton, Yong Guo, Claudia Lucchinetti, Sean J. Pittock, Anastasia Zekeridou

    Autoimmune movement disorders are increasingly recognized, but isolated tremor is extremely rare. We describe a 70‐year‐old male with rapidly progressive, severe postural and intention tremor and weight loss. His cerebrospinal fluid was inflammatory and harbored a neural tissue‐restricted antibody. The autoantigen was identified by immunoprecipitation and mass spectrometry and confirmed by antigen‐specific assays to be specific for tenascin‐R. He was investigated for cancer and diagnosed with follicular lymphoma that expressed tenascin‐R suggesting a paraneoplastic origin; cancer treatment and immunotherapy led to complete recovery. With this individualized patient approach and antibody discovery, we expand the spectrum of antibodies accompanying autoimmune hyperkinetic movement disorders. ANN NEUROL 2023;94:502–507